The β-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the α7 nicotinic acetylcholine receptor

Journal of Neurochemistry

Volumn 101, Issue 6, 2007, Pages 1527-1538

  Small, David H ^a   Maksel, Danuta ^a   Kerr, Megan L ^a   Ng, Judy ^a   Hou, Xu ^a   Chu, Cindy ^b   Mehrani, Hossein ^c   Unabia, Sharon ^a   Azari, Michael F ^a   Loiacono, Richard ^d   Aguilar, Marie Isabel ^a   Chebib, Mary ^b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Amyloid; Cholinergic; Dementia; Nicotinic; Toxicity

Indexed keywords

ALPHA BUNGAROTOXIN; AMYLOID BETA PROTEIN[1-42]; CELL SURFACE RECEPTOR; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR ALPHA7; MEMBRANE LIPID; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ANISOTROPY; ARTICLE; BINDING SITE; BRAIN HOMOGENATE; BRAIN SLICE; CELL DISRUPTION; CELL MEMBRANE; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; EXPERIMENTATION; FEMALE; FLUORESCENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEUROTOXICITY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RAT; SURFACE PLASMON RESONANCE; XENOPUS;

ACONITINE; AMYLOID BETA-PROTEIN; ANIMALS; BUNGAROTOXINS; CELL LINE, TUMOR; CELL MEMBRANE; FEMALE; FLUORESCENCE POLARIZATION; HIPPOCAMPUS; HUMANS; MEMBRANE FLUIDITY; MEMBRANE LIPIDS; NEUROBLASTOMA; OOCYTES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SURFACE PLASMON RESONANCE; TAU PROTEINS; TRANSFECTION; XENOPUS LAEVIS;

RATTUS;

EID: 34249823327     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04444.x     Document Type: Article

References (62)

1. Abe K. Saito H. (1999) Both oxidative stress-dependent and independent effects of amyloid beta protein are detected by 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction assay. Brain Res. 830, 146 154.
2. Aguilar M. I. Small D. H. (2005) Surface plasmon resonance for the analysis of β-amyloid interactions and fibril formation in Alzheimer's disease research. Neurotox. Res. 7, 17 27.
3. Alkondon M. Albuquerque E. X. (2004) The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog. Brain Res. 145, 109 120.
4. Antollini S. S. Barrantes F. J. (2002) Unique effects of different fatty acid species on the physical properties of the torpedo acetylcholine receptor membrane. J. Biol. Chem. 277, 1249 1254.
5. Arias E., Gallego-Sandin S., Villarroya M., Garcia A. G. Lopez M. G. (2005) Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. J. Pharmacol. Exp. Ther. 315, 1346 1353.
6. Baenziger J. E., Darsaut T. E. Morris M. L. (1999) Internal dynamics of the nicotinic acetylcholine receptor in reconstituted membranes. Biochemistry 38, 4905 4911.
7. Baenziger J. E., Morris M. L., Darsaut T. E. Ryan S. E. (2000) Effect of lipid composition on the conformational equilibria of the nicotinic acetylcholine receptor. J. Biol. Chem. 275, 777 784.
8. Barnham K. J., Cappai R., Beyreuther K., Masters C. L. Hill A. F. (2006) Delineating common molecular mechanisms in Alzheimer's and prion diseases. Trends Biochem. Sci. 31, 465 72.
9. Broide R. S. Leslie F. M. (1999) The alpha7 nicotinic acetylcholine receptor in neuronal plasticity. Mol. Neurobiol. 20, 1 16.
10. Broide R. S., Robertson R. T. Leslie F. M. (1996) Regulation of alpha7 nicotinic acetylcholine receptors in the developing rat somatosensory cortex by thalamocortical afferents. J. Neurosci. 16, 2956 2971.
11. Brown D. A. London E. (1998) Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14, 111 136.
12. Brusés J. L., Chauvet N. Rutishauser U. (2001) Membrane lipid rafts are necessary for the maintenance of the (alpha)7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons. J. Neurosci. 21, 504 512.
13. Butterfield D. A. Boyd-Kimball D. (2005) The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity. Biochim. Biophys. Acta 1703, 149 156.
14. Chen L., Yamada K., Nabeshima T. Sokabe M. (2006) alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats. Neuropharmacology 50, 254 268.
15. Cheung N. S., Small D. H. Livett B. G. (1993) An amyloid peptide, beta A4 25-35, mimics the function of substance P on modulation of nicotine-evoked secretion and desensitization in cultured bovine adrenal chromaffin cells. J. Neurochem. 60, 1163 1166.
16. Chochina S. V., Avdulov N. A., Igbavboa U., Cleary J. P., O'Hare E. O. Wood W. G. (2001) Amyloid beta-peptide1-40 increases neuronal membrane fluidity: role of cholesterol and brain region. J. Lipid Res. 42, 1292 1297.
17. D'Andrea M. R. Nagele R. G. (2006) Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. Curr. Pharm. Des. 12, 677 684.
18. Dineley K. T., Westerman M., Bui D., Bell K., Ashe K. H. Sweatt J. D. (2001) Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. J. Neurosci. 21, 4125 4133.
19. Dineley K. T., Bell K. A., Bui D. Sweatt J. D. (2002) beta-Amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J. Biol. Chem. 277, 25 056 25 061.
20. Dougherty J. J., Wu J. Nichols R. A. (2003) Beta-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex. J. Neurosci. 23, 6740 6747.
21. Eckert G. P., Wood W. G. Muller W. E. (2005) Membrane disordering effects of beta-amyloid peptides. Subcell. Biochem. 38, 319 337.
22. Erb E. M., Chen X., Allen S., Roberts C. J., Tendler S. J., Davies M. C. Forsen S. (2000) Characterization of the surfaces generated by liposome binding to the modified dextran matrix of a surface plasmon resonance sensor chip. Anal. Biochem. 280, 29 35.
23. Espinoza-Fonseca L. M. (2004) Molecular docking of four β-amyloid1-42 fragments on the alpha7 nicotinic receptor: delineating the binding site of the Abeta peptides. Biochem. Biophys. Res. Commun. 323, 1191 1196.
24. Espinoza-Fonseca L. M. Trujillo-Ferrara J. G. (2006) Fully flexible docking models of the complex between alpha7 nicotinic receptor and a potent heptapeptide inhibitor of the beta-amyloid peptide binding. Bioorg. Med. Chem. Lett. 16, 3519 3523.
25. Fodero L. R., Mok S. S., Losic D., Martin L. L., Aguilar M. I., Barrow C. J., Livett B. G. Small D. H. (2004) Alpha7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones. J. Neurochem. 88, 1186 1193.
26. Fu W. Jhamandas J. H. (2003) Beta-amyloid peptide activates non-alpha7 nicotinic acetylcholine receptors in rat basal forebrain neurons. J. Neurophysiol. 90, 3130 3136.
27. Götz J., Chen F., van Dorpe J. Nitsch R. M. (2001) Formation of neurofibrillary tangles in P301 l tau transgenic mice induced by Abeta 42 fibrils. Science 293, 1491 1495.
28. Götz J., Schild A., Hoerndli F. Pennanen L. (2004) Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. Int. J. Dev. Neurosci. 22, 453 465.
29. Grassi F., Palma E., Tonini R., Amici M., Ballivet M. Eusebi F. (2003) Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin-sensitive nicotinic receptors. J. Physiol. 547, 147 157.
30. Hertel C., Terzi E., Hauser N., Jakob-Rotne R., Seelig J. Kemp J. A. (1997) Inhibition of the electrostatic interaction between β-amyloid peptide and membranes prevents β-amyloid-induced toxicity. Proc. Natl Acad. Sci. USA 94, 9412 6.
31. Hou X., Richardson S. J., Aguilar M. I. Small D. H. (2005) Binding of amyloidogenic transthyretin to the plasma membrane alters membrane fluidity and induces neurotoxicity. Biochemistry 44, 11 618 11 627.
32. Kihara T., Shimohama S., Sawada H., Kimura J., Kume T., Kochiyama H., Maeda T. Akaike A. (1997) Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann. Neurol. 42, 159 163.
33. Kihara T., Shimohama S., Urushitani M., Sawada H., Kimura J., Kume T., Maeda T. Akaike A. (1998) Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res. 792, 331 334.
34. Kihara T., Sawada H., Nakamizo T., Kanki R., Yamashita H., Maelicke A. Shimohama S. (2004) Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity. Biochem. Biophys. Res. Commun. 325, 976 982.
35. Klein W. L., Krafft G. A. Finch C. E. (2001) Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum Trends Neurosci. 24, 219 224.
36. Klug G. M., Losic D., Subasinghe S. S., Aguilar M. I., Martin L. L. Small D. H. (2003) Beta-amyloid protein oligomers induced by metal ions and acid pH are distinct from those generated by slow spontaneous ageing at neutral pH. Eur. J. Biochem. 270, 4282 4293.
37. Kremer J. J. Murphy R. M. (2003) Kinetics of adsorption of beta-amyloid peptide Abeta(1-40) to lipid bilayers. J. Biochem. Biophys. Methods 57, 159 169.
38. Lee D. H. Wang H. Y. (2003) Differential physiologic responses of alpha7 nicotinic acetylcholine receptors to beta-amyloid1-40 and beta-amyloid1-42. J. Neurobiol. 55, 25 30.
39. Li X. D. Buccafusco J. J. (2003) Effect of beta-amyloid peptide 1-42 on the cytoprotective action mediated by alpha7 nicotinic acetylcholine receptors in growth factor-deprived differentiated PC-12 cells. J. Pharmacol. Exp. Ther. 307, 670 675.
40. Liu Q. Wu J. (2006) Neuronal nicotininc acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity. Acta Pharmacol. Sin. 27, 1277 1286.
41. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I. Rydel R. E. (1992) beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376 389.
42. Nagele R. G., D'Andrea M. R., Anderson W. J. Wang H. Y. (2002) Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 110, 199 211.
43. Pettit D. L., Shao Z. Yakel J. L. (2001) beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. J. Neurosci. 21, RC120.
44. Postuma R. B., He W., Nunan J., Beyreuther K., Masters C. L., Barrow C. J. Small D. H. (2000) Substrate-bound beta-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures. J. Neurochem. 74, 1122 1130.
45. Pugh P. C. Berg D. K. (1994) Neuronal acetylcholine receptors that bind alpha-bungarotoxin mediate neurite retraction in a calcium-dependent manner. J. Neurosci. 14, 889 896.
46. Pym L., Kemp M., Raymond-Delpech V., Buckingham S., Boyd C. A. Sattelle D. (2005) Subtype-specific actions of beta-amyloid peptides on recombinant human neuronal nicotinic acetylcholine receptors (alpha7, alpha4beta2, alpha3beta4) expressed in Xenopus laevis oocytes. Br. J. Pharmacol. 146, 964 971.
47. Shaw S., Bencherif M. Marrero M. B. (2002) Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. J. Biol. Chem. 277, 44 920 44 924.
48. Si M. L., Long C., Yang D. I., Chen M. F. Lee T. J. (2005) Statins prevent beta-amyloid inhibition of sympathetic alpha7-nAChR-mediated nitrergic neurogenic dilation in porcine basilar arteries. J. Cereb. Blood Flow Metab. 25, 1573 1585.
49. Small D. H. Fodero L. R. (2002) Cholinergic regulation of synaptic plasticity as a therapeutic target in Alzheimer's disease. J. Alzheimers Dis. 4, 349 355.
50. Small D. H., Mok S. S. Bornstein J. C. (2001) Alzheimer's disease and Abeta toxicity: from top to bottom. Nat. Rev. Neurosci. 2, 595 598.
51. Snyder E. M., Nong Y., Almeida C. G. et al. (2005) Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8, 1051 1058.
52. Sperotto M. M., May S. Baumgaertner A. (2006) Modelling of proteins in membranes. Chem. Phys. Lipids 141, 2 29.
53. Spinelli S., Ballard T., Feldon J., Higgins G. A. Pryce C. R. (2006) Enhancing effects of nicotine and impairing effects of scopolamine on distinct aspects of performance in computerized attention and working memory tasks in marmoset monkeys. Neuropharmacology 51, 238 250.
54. Subasinghe S., Unabia S., Barrow C. J., Mok S. S., Aguilar M. I. Small D. H. (2003) Cholesterol is necessary both for the toxic effect of Ab peptides on vascular smooth muscle cells and for Ab binding to vascular smooth muscle cell membranes. J. Neurochem. 84, 471 479.
55. Svensson A. L. Nordberg A. (1999) Beta-estradiol attenuate amyloid beta-peptide toxicity via nicotinic receptors. Neuroreport 10, 3485 3489.
56. Walsh D. M. Selkoe D. J. (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44, 181 193.
57. Wang H. Y., Lee D. H., D'Andrea M. R., Peterson P. A., Shank R. P. Reitz A. B. (2000a) beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J. Biol. Chem. 275, 5626 5632.
58. Wang H. Y., Lee D. H., Davis C. B. Shank R. P. (2000b) Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. J. Neurochem. 75, 1155 1161.
59. Wang H. Y., D'Andrea M. R. Nagele R. G. (2002) Cerebellar diffuse amyloid plaques are derived from dendritic Abeta42 accumulations in Purkinje cells. Neurobiol. Aging 23, 213 223.
60. Wang H. Y., Li W., Benedetti N. J. Lee D. H. (2003) Alpha 7 nicotinic acetylcholine receptors mediate beta-amyloid peptide-induced tau protein phosphorylation. J. Biol. Chem. 278, 31 547 31 553.
61. Whiteaker P., Davies A. R., Marks M. J., Blagbrough I. S., Potter B. V., Wolstenholme A. J., Collins A. C. Wonnacott S. (1999) An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain. Eur. J. Neurosci. 11, 2689 2696.
62. Wu J., Kuo Y. P., George A. A., Xu L., Hu J. Lukas R. J. (2004) beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells. J. Biol. Chem. 279, 37 842 37 851.